Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

WST Financial Statements and Analysis

NYSE : WST

West Pharmaceutical Services, Inc.

$201.82
-0.675-0.33%
Open: 3:35 PM
81.66
BESG ScoreESG Rating

WST FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

WST Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue746.90M702.00M695.40M732.00M747.40M
cost of revenue482.20M470.70M465.20M453.80M459.10M
gross profit264.70M231.30M230.20M278.20M288.30M
gross profit ratio0.3540.3290.3310.380.386
research and development expenses15.50M17.50M17.60M18.40M16.40M
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses83.50M83.00M86.70M90.00M89.00M
other expenses03.30M-3.10M-1.10M-1.80M
operating expenses99.00M100.50M107.40M108.40M105.40M
cost and expenses581.20M571.20M572.60M562.20M564.50M
interest income4.60M4.00M6.20M9.40M-8.80M
interest expense700.00K1.50M1.60M1.20M2.90M
depreciation and amortization40.20M38.90M35.60M35.90M35.70M
ebitda205.40M168.40M161.20M214.00M218.60M
ebitda ratio0.2750.2420.2280.2920.292
operating income161.30M130.80M122.80M160.90M177.30M
operating income ratio0.2160.1860.1770.220.237
total other income expenses net3.20M7.00M4.60M-9.80M-1.80M
income before tax164.50M128.70M127.40M168.20M187.00M
income before tax ratio0.220.1830.1830.230.25
income tax expense32.40M21.90M16.40M34.50M29.40M
net income136.00M111.30M115.30M137.00M161.30M
net income ratio0.1820.1590.1660.1870.216
eps1.871.521.571.852.17
eps diluted1.851.511.551.832.14
weighted average shs out72.80M73.00M73.50M74.10M74.30M
weighted average shs out dil73.40M73.70M74.30M75.00M75.30M
Graph

WST Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents490.90M446.20M601.80M853.90M898.60M
short term investments00000
cash and short term investments490.90M446.20M601.80M853.90M898.60M
net receivables524.30M502.00M543.90M512.00M519.10M
inventory401.20M419.20M429.90M434.70M431.80M
other current assets134.20M115.60M117.30M135.80M122.80M
total current assets1.551B1.483B1.693B1.936B1.972B
property plant equipment net1.711B1.635B1.545B1.513B1.408B
goodwill108.80M107.30M107.60M108.50M106.80M
intangible assets12.30M12.90M13.90M15.10M15.70M
goodwill and intangible assets121.10M120.20M121.50M123.60M122.50M
long term investments217.50M198.20M202.50M210.00M195.40M
tax assets37.60M33.90M21.00M25.70M17.30M
other non current assets37.40M19.10M19.00M21.30M38.80M
total non current assets2.125B2.006B1.909B1.893B1.782B
other assets00000
total assets3.675B3.489B3.602B3.83B3.755B
account payables224.30M211.70M240.10M242.40M219.80M
short term debt19.90M154.10M151.40M151.70M71.70M
tax payables33.40M16.90M16.80M31.00M15.00M
deferred revenue016.90M16.80M41.70M15.00M
other current liabilities238.90M251.00M239.20M236.00M227.00M
total current liabilities516.50M633.70M648.40M671.80M533.50M
long term debt284.90M159.90M155.20M157.30M235.10M
deferred revenue non current2.20M87.00M47.50M48.20M1.50M
deferred tax liabilities non current9.40M13.70M12.70M12.70M16.50M
other non current liabilities112.20M105.30M104.40M58.50M99.90M
total non current liabilities406.50M278.90M273.30M276.70M353.00M
other liabilities00000
capital lease obligations102.20M87.00M100.40M102.20M99.50M
total liabilities923.00M912.60M921.70M948.50M886.50M
preferred stock00000
common stock18.80M18.80M18.80M18.80M18.80M
retained earnings3.857B3.721B3.624B3.523B3.416B
accumulated other comprehensive income loss-136.30M-216.90M-192.30M-143.80M-223.00M
other total stockholders equity-987.30M-946.00M-770.00M-517.40M-343.50M
total stockholders equity2.752B2.577B2.681B2.881B2.868B
total equity2.752B2.577B2.681B2.881B2.868B
total liabilities and stockholders equity3.675B3.489B3.602B3.83B3.755B
minority interest00000
total investments217.50M198.20M202.50M210.00M195.40M
total debt304.80M314.00M306.60M309.00M306.80M
net debt-186.10M-132.20M-295.20M-544.90M-591.80M
Graph

WST Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax00023.40M-192.00M
stock based compensation5.10M4.30M5.00M1.40M5.90M
change in working capital-100.00K14.10M-34.60M26.90M24.80M
accounts receivables00000
inventory00000
accounts payables00000
other working capital-100.00K14.10M-34.60M26.90M0
other non cash items-1.10M78.50M-3.70M14.50M194.40M
net cash provided by operating activities180.10M165.00M118.20M239.10M230.10M
investments in property plant and equipment-81.30M-100.20M-90.60M-108.70M-95.80M
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites-82.10M-1.00M0-100.00K100.00K
net cash used for investing activites-82.10M-101.20M-90.60M-108.80M-95.70M
debt repayment-3.50M-23.40M-600.00K-600.00K-600.00K
common stock issued-23.60M6.80M16.80M3.10M20.40M
common stock repurchased-52.40M-187.10M-272.40M-177.10M-28.10M
dividends paid-14.50M-14.60M-14.70M-14.80M-14.00M
other financing activites6.00M41.90M-100.00K-100.00K-300.00K
net cash used provided by financing activities-64.40M-218.30M-271.00M-189.50M-22.30M
effect of forex changes on cash11.10M-1.10M-8.70M14.50M-9.80M
net change in cash44.70M-155.60M-252.10M-44.70M-566.20M
cash at end of period490.90M446.20M601.80M853.90M230.10M
cash at beginning of period446.20M601.80M853.90M898.60M796.30M
operating cashflow180.10M165.00M118.20M239.10M230.10M
capital expenditure-81.30M-100.20M-90.60M-108.70M-95.80M
free cash flow98.80M64.80M27.60M130.40M134.30M
Graph

Frequently Asked Questions

How did West Pharmaceutical Services, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, WST generated $746.90M in revenue last quarter, while its costs came in at $482.20M.

Last quarter, how much Gross Profit did West Pharmaceutical Services, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. West Pharmaceutical Services, Inc. reported a $264.70M Gross Profit for the quarter ended Sep 30, 2024.

Have WST's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. WST incurred $99.00M worth of Operating Expenses, while it generated $161.30M worth of Operating Income.

How much Net Income has WST posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from West Pharmaceutical Services, Inc., the company generated $136.00M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did West Pharmaceutical Services, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to West Pharmaceutical Services, Inc. as of the end of the last quarter was $490.90M.

What are WST's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, WST had Total Net Receivables of $524.30M.

In terms of Total Assets and Current Assets, where did West Pharmaceutical Services, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of WST were $1.55B, while the Total Assets stand at $3.68B.

As of the last quarter, how much Total Debt did West Pharmaceutical Services, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of WST's debt was $304.80M at the end of the last quarter.

What were WST's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, WST reported total liabilities of $923.00M.

How much did WST's Working Capital change over the last quarter?

Working Capital Change for WST was -$100.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

WST generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. WST generated $180.10M of Cash from Operating Activities during its recently reported quarter.

What was WST's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. WST reported a $44.70M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph